Marianne Brüggemann

Chief Tech/Sci/R&D Officer at Open Monoclonal Technology, Inc.

Health Technology

Commercial Services

Profile

Marianne Brüggemann is a Research Director at Open Monoclonal Technology, Inc. since 2008.
Prior to this, she was the Head-Laboratory of Developmental Immunology at The Babraham Institute.

Marianne Brüggemann active positions

Companies	Position	Start
Open Monoclonal Technology, Inc. Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	2007-12-31

All active positions of Marianne Brüggemann

Former positions of Marianne Brüggemann

Companies	Position	End
The Babraham Institute The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.	Corporate Officer/Principal	-

See the detail of Marianne Brüggemann's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marianne Brüggemann's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Open Monoclonal Technology, Inc. Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA.	Health Technology
The Babraham Institute The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.	Commercial Services